Omeprazol Teva (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Teva, is a Proton Pump Inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat gastro‑reflux disease and related conditions in adults and children. GNH USA supplies Omeprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑associated ulcer prevention: lowers risk of ulcer development in chronic NSAID users.

Adverse reactions to omeprazole vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea or vomiting: transient gastrointestinal upset. - Abdominal pain or flatulence: mild discomfort. - Constipation: occasional bowel habit change. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures: increased risk with long‑term use. - Acute interstitial nephritis: kidney inflammation. - Liver enzyme elevation: signs of hepatic stress.

When using omeprazole, consider the following safety measures: - Assess renal function: adjust use in severe renal impairment. - Review hepatic status: use with caution in moderate to severe liver disease. - Monitor for infections: prolonged therapy may increase risk of gastrointestinal infections. - Evaluate bone health: long‑term use may affect calcium absorption. - Consider drug‑interaction potential: assess concomitant medications. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole may interact with several medicines; clinical relevance varies.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - Dasatinib: lowered plasma concentrations.

Moderate Interaction ​​​  ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​ ​ ​  ​  ​:   -